 |
인쇄하기
취소
|
Kuhnil to launch Omaco, a triglyceride lowering therapy.
Kuhnil will launch Omaco (omega-3 fatty acid ethylester 90), a triglyceride lipemia therapy in May.
The company said that Omaco was developed by Pronova, a Norway company, under the U. S. FDA approval as the first therapeutic drug containing omega-3 fatty acid as a main active ingredient, which had been used as a functional food supplement.
It was approved by the KFDA for the treatment...
The company said that Omaco was developed by Pronova, a Norway company, under the U. S. FDA approval as the first therapeutic drug containing omega-3 fatty acid as a main active ingredient, which had been used as a functional food supplement.
It was approved by the KFDA for the treatment...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.